Troy Harasym

Troy Harasym has worked in various roles within the biopharmaceutical industry. Troy is currently the Vice President of DMPK & Translational Sciences at Arbutus Biopharma Corporation since October 2021. Prior to this, they served as the Executive Director of DMPK & Translational Research at the same company from July 2020 to September 2021. Before joining Arbutus Biopharma Corporation, Troy worked at Tekmira Pharmaceuticals as the Director of Oncology from April 2013 to June 2015. From September 2010 to January 2013, they held the position of Sr. Director of Biological Evaluation at Celator Pharmaceuticals. Prior to that, Troy had various roles at Celator Pharmaceuticals and Inex Pharmaceuticals, including Director of Drug Screening and Research Scientist.

Troy Harasym completed a Bachelor of Science degree in Biochemistry from The University of British Columbia from 1986 to 1990. Troy then pursued a Doctor of Philosophy (Ph.D.) in Biochemistry and Molecular Biology from The University of British Columbia from 1992 to 1997.